Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is TATA Health International Holdings Days Payable?
TATA Health International HoldingsHKSE:01255 -0.91%22 Days Payable is 1,003.82 as of Dec. 2025, which is 4373% above its 10-year median of 22.44. GuruFocus rates HKSE:01255 with a GF Score™ of 22/100 and a GF Value™ of HK$0.22 (Significantly Overvalued). The stock has 8 warning signs investors should review. Among 1,020 Manufacturing - Apparel & Accessories companies, TATA Health International Holdings ranks better than 97.84% on this metric.
HKSE:01255'
s Days Payable Range Over the Past 10 Years
Min: 5.42 Med: 22.44 Max: 864.06
Current: 864.06
During the past 13 years, TATA Health International Holdings's highest Days Payable was 864.06. The lowest was 5.42. And the median was 22.44.
HKSE:01255's Days Payable is ranked better than 97.84% of 1020
companies
in the Manufacturing - Apparel & Accessories industry
Industry Median: 54.315
vs HKSE:01255: 864.06
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TATA Health International Holdings Days Payable Chart
HKSE:01255 vs NKE, DECK, ONON: Days Payable Comparison
For the Footwear & Accessories subindustry, TATA Health International Holdings's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
TATA Health International Holdings Days Payable vs Manufacturing - Apparel & Accessories Industry
For the Manufacturing - Apparel & Accessories industry and Consumer Cyclical sector, TATA Health International Holdings's Days Payable distribution charts can be found below:
* The bar in red indicates where TATA Health International Holdings's Days Payable falls into.
TATA Health International Holdings Days Payable Calculation
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TATA Health International Holdings (HKSE:01255) has a Days Payable of 1,003.82 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on TATA Health International Holdings and its competitors. This is 4373% above median its historical median of 22.44. Over the past decade, TATA Health International Holdings' Days Payable has ranged from 5.42 to 864.06. According to the industry distribution chart, TATA Health International Holdings ranks #22 out of 1020 companies in the Manufacturing - Apparel & Accessories industry, placing it in the top 2.2%.
Is TATA Health International Holdings' Days Payable too high?
TATA Health International Holdings' current Days Payable of 1,003.82 is 4373% above median its 10-year median of 22.44. Over the past 10 years, this metric has ranged from a low of 5.42 to a high of 864.06. The Manufacturing - Apparel & Accessories industry median Days Payable is 54.32. TATA Health International Holdings' value of 1,003.82 is 1748.1% above this industry median. Based on the distribution chart, TATA Health International Holdings ranks #22 out of 1020 companies in the Manufacturing - Apparel & Accessories industry, which is in the top quartile — a strong position relative to peers. Overall, TATA Health International Holdings has a GF Score™ of 22/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does TATA Health International Holdings' Days Payable compare to NKE and DECK?
According to the Manufacturing - Apparel & Accessories industry distribution chart, TATA Health International Holdings ranks #22 out of 1020 companies for Days Payable. This places TATA Health International Holdings in the top 2% of its industry — outperforming the majority of peers. The industry median Days Payable is 54.32. TATA Health International Holdings' value of 1,003.82 is 1748.1% above this benchmark. Historically, TATA Health International Holdings' own Days Payable has ranged from 5.42 to 864.06 over the past decade. While the company's 10-year median is 22.44 vs. the industry median of 54.32, TATA Health International Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Manufacturing - Apparel & Accessories company?
The median Days Payable among Manufacturing - Apparel & Accessories companies is 54.32, based on 1,020 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. TATA Health International Holdings's current Days Payable of 1,003.82 is 1748.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on TATA Health International Holdings and its competitors. For the Manufacturing - Apparel & Accessories industry, the median Days Payable is 54.32 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. TATA Health International Holdings's current Days Payable is 1,003.82, which is 4373% above median its own 10-year median of 22.44. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TATA Health International Holdings stock overvalued right now?
Based on GuruFocus' analysis, TATA Health International Holdings (HKSE:01255) is currently considered Significantly Overvalued. The stock's GF Value™ is HK$0.22, compared to a current price of HK$2.18 — trading 890.9% above its estimated fair value. The current Days Payable is 1,003.82, which is 4373% above median its 10-year median of 22.44 and 1748.1% above the Manufacturing - Apparel & Accessories industry median of 54.32. TATA Health International Holdings' overall GF Score™ is 22/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For TATA Health International Holdings (HKSE:01255), the current Days Payable is 1,003.82 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is TATA Health International Holdings (HKSE:01255) Overvalued in 2026?
Based on GuruFocus' analysis, TATA Health International Holdings stock appears to be overvalued.
The current stock price of HK$2.18 is trading 890.9% above its estimated GF Value™ of HK$0.22.
GuruFocus considers TATA Health International Holdings to be Significantly Overvalued.
Key valuation signals for HKSE:01255:
Days Payable: 1,003.82 (4373% above median its 10-year median of 22.44)
GF Value™: HK$0.22 vs. price of HK$2.18 (890.9% above fair value)
Industry Position: 1748.1% above the Manufacturing - Apparel & Accessories median (#22 of 1020)
No single metric tells the full story. See the HKSE:01255 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
TATA Health International Holdings Business Description
TATA Health International Holdings Ltd is an investment holding company. Through its subsidiaries, the company operates in four segments: Trading of footwear products, Trading of healthcare products, Financial services, and Online medical services. The majority of its revenue comes from the Trading of footwear products. Geographically, the Group generates maximum revenue from Hong Kong, and the rest from Macau.
22GF Score
Get the complete analysis for HKSE:01255
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:01255 has been successfully added to your 
